Evidence map›Paper›PMID 28633614›Full record

ArticleLeukemia & lymphoma2018

Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing.

Karl Kashofer, Max Gornicec, Karin Lind, Veronica Caraffini, Silvia Schauer, Christine Beham-Schmid, Albert Wölfler, Gerald Hoefler, Heinz Sill, Armin Zebisch

Open access · hybridAbstract readLetter
In one paragraph

Article in Leukemia & lymphoma, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Article
  6. [A case of isolated myeloid sarcoma initially presenting as a mediastinal mass].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Diagnostic Approaches in Myeloid Sarcoma.Current issues in molecular biology · 2025
    Review
  13. Review
  14. Review
  15. Gene Mutations and Targeted Therapies of Myeloid Sarcoma.Current treatment options in oncology · 2023
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Karl Kashofera Institute of Pathology , Medical University of Graz , Graz , Austria.
Max Gornicecb Division of Hematology , Medical University of Graz , Graz , Austria.
Karin Lindb Division of Hematology , Medical University of Graz , Graz , Austria.
Veronica Caraffinib Division of Hematology , Medical University of Graz , Graz , Austria.
Silvia Schauera Institute of Pathology , Medical University of Graz , Graz , Austria.
Christine Beham-Schmida Institute of Pathology , Medical University of Graz , Graz , Austria.
Albert Wölflerb Division of Hematology , Medical University of Graz , Graz , Austria.
Gerald Hoeflera Institute of Pathology , Medical University of Graz , Graz , Austria.
Heinz Sillb Division of Hematology , Medical University of Graz , Graz , Austria.
Armin Zebischb Division of Hematology , Medical University of Graz , Graz , Austria.
Medical University of Graz · AT

Funding

Austrian Science Fund FWF P 26619
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biomarkers, TumorMutationTranslocation, GeneticCombined Modality TherapyGenetic Association StudiesGenetic Predisposition to DiseaseHigh-Throughput Nucleotide SequencingHumansNeoplasm StagingPrognosisSarcoma, MyeloidTreatment OutcomeBiomarkers, Tumor

Identifiers

PMID28633614
PMCPMC5743000
OpenAlexW2683286743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.